In 2023, hospital discharges for malignant neoplasm of the bladder in the UK stood at 25.48 thousand. Forecasted figures indicate a decline from 24.83 thousand in 2024 to 22.35 thousand by 2028. Year-on-year variations show a decreasing trend with -2.57% from 2024 to 2025, followed by -2.56% in 2026, -2.63% in 2027, and -2.62% in 2028. The compound annual growth rate (CAGR) from 2024 to 2028 is -2.63%, illustrating a consistent annual decrease.

Future trends to monitor include:

Advancements in early detection and treatment potentially decreasing hospital stays.
Policy changes or public health initiatives impacting bladder cancer care.
Demographic shifts influencing incidence and discharge rates.